NQO1 and myeloid sarcoma: A case–control study involving 254 MS patients and 370 healthy donors has revealed a significantly greater occurrence of NQO1 variant genotypes in patients with relapsing–remitting MS compared with controls, suggesting the role of the NQO1 gene as a risk factor for MS [10].